Activation of peroxisome proliferator-activated receptor γ does not explain the antiproliferative activity of the nonsteroidal anti-inflammatory drug indomethacin on human colorectal cancer cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 2, 2003, Pages 632-637

  Hawcroft, G ^a   Gardner, S H ^a   Hull, M A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL DIVISION; COLORECTAL NEOPLASMS; DNA, NEOPLASM; GENES, REPORTER; HUMANS; INDOMETHACIN; LUCIFERASES; PLASMIDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037405882     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.048769     Document Type: Article

References (40)

1. Adams M, Reginato MJ, Shao D, Lazar MA, and Chatterjee VK (1997) Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272:5128-5132.
2. Adamson DJ, Frew D, Tatoud R, Wolf CR, and Palmer CAN (2002) Diclofenac antagonizes peroxisome proliferator-activated receptor-γ signaling. Mol Pharmacol 61:7-12.
3. Baek SJ, Wilson LC, Lee C-H, and Eling TE (2002) Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene. J Pharmacol Exp Ther 301:1126-1131.
4. Brockman JA, Gupta RA, and DuBois RN (1998) Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 115:1049-1055.
5. Brown WA, Skinner SA, Malcontenti-Wilson C, Vogiagis D, and O'Brien PE (2001) Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation. Gut 48:660-666.
6. Chapple KS, Scott N, Guillou PJ, Coletta PL, and Hull MA (2002) Analysis of cyclooxygenase expression in human colorectal adenomas. Dis Colon Rectum 45:1316-1324.
7. -/+ mice. Prostaglandins Leukotr Essent Fatty Acids 62:269-275.
8. Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C, Tiano HF, Morham SG, Smithies O, and Langenbach R (2000) Genetic disruption of Ptgs.1, as well as of Ptgs.2, reduces intestinal tumorigenesis in Min mice. Cancer Res 60:4705-4708.
9. Dihlmann S, Siermann A, and von Knebel Doeberitz M (2001) The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catertin/TCF-4 signaling. Oncogene 20:645-653.
10. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812.
11. Garcia Rodriguez LA and Huerta-Alvarez C (2001) Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs. Epidemiology 12:88-93.
12. Girnun GD, Smith WM, Drori S, Sarraf P, Mueller E, Eng C, Nambiar P, Rosenberg DW, Bronson RT, Edelmann W, et al. (2002) APC-dependent suppression of colon carcinogenesis by PPARγ. Proc Natl Acad Sci USA 99:13771-13776.
13. Gupta RA and DuBois RN (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Cancer Rev 1:11-21.
14. Gupta RA and DuBois RN (2002) Controversy: PPARγ as a target for treatment of colorectal cancer. Am J Physiol Gastrointest Liver Physiol 283:G266-G269.
15. Gurnell M, Wentworth JM, Agostini M, Adams M, Collingwood TN, Provenzano C, Browne PO, Rajanayagam O, Burris TP, Schwabe JW, et al. (2000) A dominant-negative peroxisome proliferator-activated receptor γ (PPARγ) mutant is a constitutive repressor and inhibits PPARγ-mediated adipogenesis. J Biol Chem 275:5754-5759.
16. Hawcroft G, D'Amico M, Albanese C, Markham AF, Pestell RG, and Hull MA (2002) Indomethacin induces differential expression of β-catenin, γ-catenin and T-cell factor target genes in human colorectal cancer cells. Carcinogenesis 23:107-114.
17. Hirota C, Lida M, Aoyagi K, Matsumoto T, Tada S, Yao T, and Fujishima M (1996) Effect of indomethacin suppositories on rectal polyposis in patients with familial adenomatous polyposis. Cancer 78:1660-1665.
18. Hixson LJ, Alberts DS, Krutzsch M, Einsphar J, Brendel K, Gross PH, Shipp Paranka N, Baier M, Emerson S, Pamukcu R, et al. (1994) Anti-proliferative effect of nonsteroidal anti-inflammatory drugs against human colon cancer cells. Cancer Epidemiol Biomarkers Prev 3:433-438.
19. Hucker HB, Zacchei AG, Cox SV, Brodie DA, and Cantwell NHR (1966) Studies on the absorption, distribution and excretion of indomethacin in various species. J Pharmacol Exp Ther 153:237-249.
20. 2 synthases by ibuprofen, naproxen and indomethacin. Biochem Pharmacol 62:1587-1595.
21. Kang H-J, Song M-J, Choung SY, Kim SJ, and Lee M-O (2000) Transcriptional induction of Nur77 by indomethacin that results in apoptosis of colon cancer cells. Biol Pharm Bull 23:815-819.
22. Kim K-S, Baek SJ, Flake GP, Loftin CD, Calvo BF, and Eling TE (2002) Expression and regulation of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) in human and mouse tissue. Gastroenterology 122:1388-1398.
23. Kim TI, Jin SH, Kim WH, Kang EH, Choi KY, Kim HJ, Shin SK, and Kang JK (2001) Prolonged activation of mitogen-activated protein kinases during NSAID-induced apoptosis in HT-29 colon cancer cells. Int J Colorectal Dis 16:167-173.
24. Kirtikara K, Swangkul S, and Ballou LR (2001) The analysis of nonsteroidal anti-inflammatory drug selectivity in prostaglandin G/H synthase (PGHS)-null cells. Inflamm Res 50:327-332.
25. Kokoska ER, Smith GS, Wolff AB, Deshpande Y, and Millet TA (1999) Nonsteroidal anti-inflammatory drugs attenuate epidermal growth factor-induced proliferation independent of prostaglandin synthesis inhibition. J Surg Res 84:186-192.
26. Kwan KC, Breault GO, Umbenhauer ER, McMahon FG, and Duggan DE (1976) Kinetics of indomethacin absorption, elimination and enterohepatic circulation in man. J Pharmacokinet Biopharm 4:255-280.
27. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, and Kliewer SA (1997) Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272:3406-3410.
28. Marx J (2001) Anti-inflammatories inhibit cancer growth - but how? Science (Wash DC) 291:581-582.
29. Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapelle A, Spiegelman BM, and Eng C (1999) Loss-of-function mutations in PPARγ associated with human colon cancer. Mol Cell 3:799-804.
30. Shiff SJ and Rigas B (1997) Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 113:1992-1998.
31. Shiff SJ and Rigas B (1999) The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal anti-inflammatory drugs (NSAIDs). J Exp Med 190:445-450.
32. Shimada T, Kojima K, Yoshiura K, Hirashi H, and Terano A (2002) Characteristics of the peroxisome proliferator activated receptor γ (PPARγ) ligand induced apoptosis in colon cancer cells. Gut 50:658-664.
33. Smith M-L, Hawcroff G, and Hull MA (2000) The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer 36:664-674.
34. Tanaka Y, Tanaka T, and Ishitsuka H (1989) Antitumor activity of indomethacin in mice bearing advanced colon 26 carcinoma compared with those with early transplants. Cancer Res 49:5935-5939.
35. Tegeder I, Pfeilschifter J, and Geisslinger G (2001) Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 15:2057-2072.
36. Turchanowa L, Dauletbaev N, Milovic V, and Stein J (2001) Nonsteroidal anti-inflammatory drugs stimulate spermidine/spermine acetyltransferase and deplete polyamine content in colon cancer cells. Eur J Clin Investig 31:887-893.
37. Wang C, Fu M, D'Amico M, Albanese C, Zhou J-N, Brownlee M, Lisanti MP, Chatterjee VKK, Lazar MA, and Pestell RG (2001) Inhibition of cellular proliferation through IκB kinase-independent and peroxisome proliferator-activated receptor γ-dependent repression of cyclin D1. Mol Cell Biol 21:3057-3070.
38. Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, and Kawai S (2002) Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor γ in rheumatoid synovial cells. J Pharmacol Exp Ther 302:18-25.
39. Zhang L, Yu J, Ho Park B, Kinzler KW, and Vogelstein B (2000) Role of BAX in the apoptotic response to anticancer agents. Science (Wash DC) 290:989-992.
40. Zhang X, Morham SG, Langenbach R, and Young DA (1999) Malignant transformation and antineoplastic actions of nonsteroidal anti-inflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J Exp Med 190:451-459.